[1] |
Alzheimer's Association. 2017 Alzheimer's disease facts and figures[J]. Alzheimer's Dement, 2017, 13(4): 325−373. DOI: 10.1016/j.jalz.2017.02.001. |
[2] |
Scheltens P, Blennow K, Breteler MMB, et al. Alzheimer's disease[J]. Lancet, 2016, 388(10043): 505−517. DOI: 10.1016/S0140−6736(15)01124−1. |
[3] |
Lista S, Hampel H. Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease[J]. Expert Rev Neurother, 2017, 17(1): 47−57. DOI: 10.1080/14737175.2016.1204234. |
[4] |
Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer's disease[J]. Lancet Neurol, 2015, 14(4): 388−405. DOI: 10.1016/S1474−4422(15)70016−5. |
[5] |
De La Monte SM, Tong M. Brain metabolic dysfunction at the core of Alzheimer's disease[J]. Biochem Pharmacol, 2014, 88(4): 548−559. DOI: 10.1016/j.bcp.2013.12.012. |
[6] |
Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease[J]. Nat Rev Neurosci, 2018, 19(11): 687−700. DOI: 10.1038/s41583−018−0067−3. |
[7] |
Stam CJ. Modern network science of neurological disorders[J]. Nat Rev Neurosci, 2014, 15(10): 683−695. DOI: 10.1038/nrn3801. |
[8] |
Bullmore E, Sporns O. The economy of brain network organization[J]. Nat Rev Neurosci, 2012, 13(5): 336−349. DOI: 10.1038/nrn3214. |
[9] |
Sporns O. Network attributes for segregation and integration in the human brain[J]. Curr Opin Neurobiol, 2013, 23(2): 162−171. DOI: 10.1016/j.conb.2012.11.015. |
[10] |
Watts DJ, Strogatz SH. Collective dynamics of 'small-world' networks[J]. Nature, 1998, 393(6684): 440−442. DOI: 10.1038/30918. |
[11] |
Oh SW, Harris JA, Ng L, et al. A mesoscale connectome of the mouse brain[J]. Nature, 2014, 508(7495): 207−214. DOI: 10.1038/nature13186. |
[12] |
Harris NG, Verley DR, Gutman BA, et al. Disconnection and hyper-connectivity underlie reorganization after TBI: A rodent functional connectomic analysis[J]. Exp Neurol, 2016, 277: 124−138. DOI: 10.1016/j.expneurol.2015.12.020. |
[13] |
Albert R, Barabási AL. Statistical mechanics of complex networks[J]. Rev Mod Phys, 2002, 74(1): 47−91. DOI: 10.1103/RevModPhys.74.47. |
[14] |
Giusti C, Ghrist R, Bassett DS. Two's company, three (or more) is a simplex: algebraic-topological tools for understanding higher-order structure in neural data[J]. J Comput Neurosci, 2016, 41(1): 1−14. DOI: 10.1007/s10827−016−0608−6. |
[15] |
Calhoun VD, Miller R, Pearlson G, et al. The Chronnectome: Time-Varying Connectivity Networks as the Next Frontier in fMRI Data Discovery[J]. Neuron, 2014, 84(2): 262−274. DOI: 10.1016/j.neuron.2014.10.015. |
[16] |
He Y, Chen Z, Evans A. Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's Disease[J]. J Neurosci, 2008, 28(18): 4756−4766. DOI: 10.1523/JNEUROSCI.0141−08.2008. |
[17] |
Supekar K, Menon V, Rubin D, et al. Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease [J/OL]. PLoS Comput Biol, 2008, 4(6): e1000100[2019-11-08]. http://dx.doi.org/10.1371/journal.pcbi.1000100. DOI:10.1371/journal.pcbi.1000100. |
[18] |
Zhao QH, Lu H, Metmer H, et al. Evaluating functional connectivity of executive control network and frontoparietal network in Alzheimer's disease[J]. Brain Res, 2018, 1678: 262−272. DOI: 10.1016/j.brainres.2017.10.025. |
[19] |
Liu Y, Yu CS, Zhang XQ, et al. Impaired Long Distance Functional Connectivity and Weighted Network Architecture in Alzheimer's Disease[J]. Cereb Cortex, 2014, 24(6): 1422−1435. DOI: 10.1093/cercor/bhs410. |
[20] |
Hahn K, Myers N, Prigarin S, et al. Selectively and progressively disrupted structural connectivity of functional brain networks in Alzheimer's disease — revealed by a novel framework to analyze edge distributions of networks detecting disruptions with strong statistical evidence[J]. Neuroimage, 2013, 81: 96−109. DOI: 10.1016/j.neuroimage.2013.05.011. |
[21] |
Bernard C, Dilharreguy B, Helmer C, et al. PCC characteristics at rest in 10-year memory decliners[J]. Neurobiol Aging, 2015, 36(10): 2812−2820. DOI: 10.1016/j.neurobiolaging.2015.07.002. |
[22] |
Dai ZJ, Yan CG, Li KC, et al. Identifying and Mapping Connectivity Patterns of Brain Network Hubs in Alzheimer's Disease[J]. Cereb Cortex, 2015, 25(10): 3723−3742. DOI: 10.1093/cercor/bhu246. |
[23] |
Huang S, Li J, Sun L, et al. Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation[J]. NeuroImage, 2010, 50(3): 935−949. DOI: 10.1016/j.neuroimage.2009.12.120. |
[24] |
Titov D, Diehl-Schmid J, Shi KY, et al. Metabolic connectivity for differential diagnosis of dementing disorders[J]. J Cereb Blood Flow Metab, 2017, 37(1): 252−262. DOI: 10.1177/0271678x15622465. |
[25] |
Duan HQ, Jiang JH, Xu J, et al. Differences in Aβ brain networks in Alzheimer's disease and healthy controls[J]. Brain Res, 2017, 1655: 77−89. DOI: 10.1016/j.brainres.2016.11.019. |
[26] |
Lo CY, Wang PN, Chou KH, et al. Diffusion Tensor Tractography Reveals Abnormal Topological Organization in Structural Cortical Networks in Alzheimer's Disease[J]. J Neurosci, 2010, 30(50): 16876−16885. DOI: 10.1523/JNEUROSCI.4136−10.2010. |
[27] |
Stam CJ, Jones BF, Nolte G, et al. Small-World Networks and Functional Connectivity in Alzheimer's Disease[J]. Cereb Cortex, 2006, 17(1): 92−99. DOI: 10.1093/cercor/bhj127. |
[28] |
Xue C, Yuan B, Yue Y, et al. Distinct Disruptive Patterns of Default Mode Subnetwork Connectivity Across the Spectrum of Preclinical Alzheimer's Disease[J]. Front Aging Neurosci, 2019, 11: 307. DOI: 10.3389/fnagi.2019.00307. |
[29] |
Dillen KNH, Jacobs HIL, Kukolja J, et al. Aberrant functional connectivity differentiates retrosplenial cortex from posterior cingulate cortex in prodromal Alzheimer's disease[J]. Neurobiol Aging, 2016, 44: 114−126. DOI: 10.1016/j.neurobiolaging.2016.04.010. |
[30] |
Yan TY, Wang WH, Yang L, et al. Rich club disturbances of the human connectome from subjective cognitive decline to Alzheimer's disease[J]. Theranostics, 2018, 8(12): 3237−3255. DOI: 10.7150/thno.23772. |
[31] |
Buckner RL, Sepulcre J, Talukdar T, et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease[J]. J Neurosci, 2009, 29(6): 1860−1873. DOI: 10.1523/JNEUROSCI.5062−08.2009. |
[32] |
Filippi M, Van Den Heuvel MP, Fornito A, et al. Assessment of system dysfunction in the brain through MRI-based connectomics[J]. Lancet Neurol, 2013, 12(12): 1189−1199. DOI: 10.1016/S1474−4422(13)70144−3. |
[33] |
Evans A, He Y, Chen Z. P1-241: Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease[J]. Alzheimer's Dement, 2008, 4(4S): T284−T285. DOI: 10.1016/j.jalz.2008.05.830. |
[34] |
Zhou HC, Jiang JH, Lu JY, et al. Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer's Disease[J]. Front Neurosci, 2019, 12: 1045. DOI: 10.3389/fnins.2018.01045. |
[35] |
Zeidán-Chuliá F, De Oliveira BH, Salmina AB, et al. Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy[J/OL]. Cell Death Dis, 2014, 5(5): e1250[2019-11-08]. https://www.nature.com/articles/cddis2014227. DOI: 10.1038/cddis.2014.227. |
[36] |
Solé-Padullés C, Bartrés-Faz D, Junqué C, et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease[J]. Neurobiol Aging, 2009, 30(7): 1114−1124. DOI: 10.1016/j.neurobiolaging.2007.10.008. |
[37] |
Kivelä M, Arenas A, Barthelemy M, et al. Multilayer networks[J]. J Complex Networks, 2014, 2(3): 203−271. DOI: 10.1093/comnet/cnu016. |
[38] |
Linnman C, Catana C, Petkov MP, et al. Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings[J]. Neuroimage Clin, 2018, 17: 680−690. DOI: 10.1016/j.nicl.2017.11.011. |
[39] |
Marchitelli R, Aiello M, Cachia A, et al. Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity[J]. NeuroImage, 2018, 176: 246−258. DOI: 10.1016/j.neuroimage.2018.04.048. |
[40] |
Qin PM, Duncan NW, Chen DYT, et al. Vascular-metabolic and GABAergic Inhibitory Correlates of Neural Variability Modulation. A Combined fMRI and PET Study[J]. Neuroscience, 2018, 379: 142−151. DOI: 10.1016/j.neuroscience.2018.02.041. |